Equity Residential (EQR) Q4 2025 Earnings Call Transcript

Mettler-Toledo International Inc. (MTD) Q4 2025 Earnings Call Transcript

Mr. Market erroneously smashed POET Technologies Inc. shares because he messed up applying dilution. We divide wealth among a growing number of shares. But new capital also generates much more wealth! POET's photonics platform will boost wealth by targeting critical speed, bandwidth, and energy efficiency needs for AI and hyperscale datacenter connectivity, with recent partnerships and orders validating progress. Operational milestones—major customer interest, strategic collaborations, and a $5M production order—underscore POET's advancing commercial viability in next-gen optical engines.

Coca-Cola remains a buy, targeting $90, due to its resilient business model and defensive qualities amid market uncertainty. KO's premium valuation is justified by stable cash flows, high margins, and global brand strength, despite trading at 25-26x forward P/E. Management expects 4-6% annual revenue growth and 7-9% EPS growth through 2026, with conservative guidance likely during leadership transition.

Amazon said it plans to invest heavily in its AI buildout this year, and investors aren't pleased.

BILL's Q2 earnings and revenues beat forecasts as strong transaction growth and rising payment volumes drive momentum.

Over a transformative year from February 2025 to 2026, Alphabet (GOOGL)'s stock jumped 74%, driven by strong revenue growth, improved margins, and rising investor confidence. Supporting this increase: impressive Q4 results, a cloud boom, AI advancements with Gemini, and a new dividend—each contributing significantly to the rally.

OMF beats Q4 earnings estimates as net interest income rises, but higher expenses and provisions weigh, sending shares down 1.4%.

MMS beats Q1 fiscal 2026 earnings estimates, but a revenue miss and softer full-year sales outlook kept the quarter mixed.

GSK secures EU approval for Nucala, an add-on maintenance treatment for chronic obstructive pulmonary disease in adults.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Peoples Bancorp (PEBO) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Phillips Edison & Company (PECO) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Snap-On (SNA) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Fifth Third Bancorp (FITB) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (APD) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does U.S. Bancorp (USB) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Valero Energy (VLO) have what it takes?

LOS ANGELES, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming February 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with the Company's September 2025 initial public offering (the “IPO”).

Shares of Micron (NASDAQ:MU) were pretty much unstoppable before shares swiftly corrected by more than 13% this week.